Hempvati

Posted • From Newsweek:

“Millions of Americans struggling with depression could benefit from the active ingredient in magic mushrooms, new research suggests. However, approval of such treatments will depend on the U.S. Food and Drug Administration (FDA).

Roughly one in 10 American adults suffer from a depressive illness each year, according to Johns Hopkins Medicine, while one in four suffer from a diagnosable mental health disorder. Previous research has suggested that psilocybin—the active ingredient in magic mushrooms—may offer effective relief against major depressive disorder symptoms, with a short, two-dose treatment course lasting for up to a year.

[...] By combining data on depression prevalence—based on national surveys—with eligibility criteria for recent landmark clinical psychotherapy trials, the team determined that between 56 and 62 percent of those currently receiving treatment for depression—that is, 5.1 to 5.6 million Americans—could qualify for psilocybin therapy if it is approved.”

Psilocybin therapy is already available in Oregon. Learn more about Oregon’s state-regulated program, which provides safe access to psilocybin therapy by visiting the Healing Advocacy Fund’s website using the link in our bio.

Posted • *****na A recent study published in NPJ Women’s Health found that a high-CBD vaginal suppository significantly reduced menstrual symptoms, including pain, mood disturbances, and reliance on pain medication. The study, involving 307 participants, highlighted that increased use of the CBD suppository led to greater symptom relief, suggesting a dose-dependent effect. Participants reported moderate to significant improvements after one and two months of use. The study underscores the potential of cannabinoid-based therapies as effective treatments for menstrual discomfort and encourages further research through randomized clinical trials. These findings add to growing evidence that CBD and other cannabis products can alleviate menstrual-related symptoms and improve overall quality of life.

Posted • *****na Pre-rolled joints generated over $4.1 billion in sales over the past 18 months, now making up 15.9% of the cannabis market. Specialty infused pre-rolls, containing ma*****na concentrate, accounted for 44% of the segment in early 2024, reflecting consumer preference for premium products. Sales volumes have increased significantly, although average prices per pre-roll have dropped from $7.80 in January 2023 to $6.50 in June 2024. Custom Cones USA, using data from Headset, found that price and THC potency are key factors driving consumer choice. Infused pre-rolls have seen rising demand since 2019, with their market share growing steadily, suggesting a shift towards more sophisticated cannabis consumption preferences.

Thank you THIS IS A NEW BEGINNING
.adgpi - or seriously KYA KARENGI HUMKO KYA PATA ? What do we know ? How do we know ????

Posted • .stoned 🌿 A New Era for Medical Care in the Philippines! 🌿

🎉 Congratulations to the Philippines! 🌿 The approval of the Medical C@nn@bis Act by the House of Representatives marks a significant step forward in providing much-needed relief and hope to countless patients.

This progressive move ensures safe, regulated access to medical c@nn@bis, opening new doors for health and wellness. Here’s to a future of healing and innovation! 🇵🇭💚

Read more: https://newsinfo.inquirer.net/1967711/house-approves-proposed-medical-cannabis-act